BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36509645)

  • 1. The M-ANNHEIM-AiP-Activity-Score is useful for predicting relapse in patients with type 1 autoimmune pancreatitis.
    Sano T; Kikuta K; Takikawa T; Matsumoto R; Hamada S; Sasaki A; Kataoka F; Ikeda M; Miura S; Kume K; Masamune A
    Pancreatology; 2023 Jan; 23(1):112-119. PubMed ID: 36509645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring and predicting disease activity in autoimmune pancreatitis with the M-ANNHEIM-AiP-Activity-Score.
    Hirth M; Vujasinovic M; Münch M; Weiss C; Löhr M; Ebert MP; Schneider A
    Pancreatology; 2018 Jan; 18(1):29-38. PubMed ID: 29158146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
    Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune Pancreatitis and Immunoglobulin G4-related Sclerosing Cholangitis: Past, Present, and Future.
    Moon SH; Kim MH
    Korean J Gastroenterol; 2022 Sep; 80(3):107-114. PubMed ID: 36156034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance steroid therapy is associated with decreased risk of malignancy and better prognosis of patients with autoimmune pancreatitis: A multicenter cohort study in Japan.
    Takikawa T; Kikuta K; Sano T; Ikeura T; Fujimori N; Umemura T; Naitoh I; Nakase H; Isayama H; Kanno A; Kamata K; Kodama Y; Inoue D; Ido A; Ueki T; Seno H; Yasuda H; Iwasaki E; Nishino T; Kubota K; Arizumi T; Tanaka A; Uchida K; Matsumoto R; Hamada S; Nakamura S; Okazaki K; Takeyama Y; Masamune A;
    Pancreatology; 2024 May; 24(3):335-342. PubMed ID: 38336506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical observation of isolated immunoglobulin G4-related sclerosing cholangitis and immunoglobulin G4 sclerosing cholangitis combined autoimmune pancreatitis].
    Jiang P; Lian M; Li B; Xiao X; Miao Q; Wang QX; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):415-419. PubMed ID: 30317753
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Usefulness of Serum Autotaxin for Early Prediction of Relapse in Male Patients with Type 1 Autoimmune Pancreatitis.
    Fukiage A; Fujino H; Miki D; Ishii Y; Serikawa M; Tsuge M; Imamura M; Aikata H; Hayes CN; Chayama K
    Dig Dis Sci; 2021 Apr; 66(4):1268-1275. PubMed ID: 32436125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis.
    Tacelli M; Celsa C; Magro B; Barresi L; Guastella S; Capurso G; Frulloni L; Cabibbo G; Cammà C
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1061-1072.e8. PubMed ID: 30312787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune pancreatitis and micronutrients.
    Vujasinovic M; Nikolic S; Gordon Achour A; Löhr JM
    Dig Liver Dis; 2023 Oct; 55(10):1375-1381. PubMed ID: 37121818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sclerosing dacryoadenitis/sialadenitis on relapse during steroid therapy in patients with type 1 autoimmune pancreatitis.
    Ishii Y; Serikawa M; Sasaki T; Fujimoto Y; Yamaguchi A; Ogawa T; Noma B; Okazaki A; Yukutake M; Ishigaki T; Chayama K
    Scand J Gastroenterol; 2019 Feb; 54(2):259-264. PubMed ID: 30915865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids.
    Kubota K; Watanabe S; Uchiyama T; Kato S; Sekino Y; Suzuki K; Mawatari H; Iida H; Endo H; Fujita K; Yoneda M; Takahashi H; Kirikoshi H; Kobayashi N; Saito S; Sugimori K; Hisatomi K; Matsuhashi N; Sato H; Tanida E; Sakaguchi T; Fujisawa N; Nakajima A
    J Gastroenterol; 2011 Jun; 46(6):834-42. PubMed ID: 21491208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease.
    Hara A; Watanabe T; Minaga K; Yoshikawa T; Kamata K; Kudo M
    World J Gastroenterol; 2021 May; 27(19):2257-2269. PubMed ID: 34040320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune pancreatitis and IgG4-related sclerosing cholangitis.
    Takuma K; Kamisawa T; Igarashi Y
    Curr Opin Rheumatol; 2011 Jan; 23(1):80-7. PubMed ID: 21124090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort.
    Naitoh I; Kamisawa T; Tanaka A; Nakazawa T; Kubota K; Takikawa H; Unno M; Masamune A; Kawa S; Nakamura S; Okazaki K;
    Dig Liver Dis; 2021 Oct; 53(10):1308-1314. PubMed ID: 33664004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and therapeutic considerations in biopsy-proven type 2 autoimmune pancreatitis: comparative analysis with biopsy-proven type 1 autoimmune pancreatitis.
    Pattabathula K; Waters PS; Hwang J; Bettington M; Singh M; Bryant RD; Cavallucci DJ; O'Rourke N
    ANZ J Surg; 2021 May; 91(5):907-914. PubMed ID: 33369858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the relationship between autoimmune pancreatitis type 2 and inflammatory bowel disease: Results from two centers and systematic review of the literature.
    Nikolic S; Lanzillotta M; Panic N; Brismar TB; Moro CF; Capurso G; Della Torre E; Löhr JM; Vujasinovic M
    United European Gastroenterol J; 2022 Jun; 10(5):496-506. PubMed ID: 35526270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can serum immunoglobulin G4 levels and age serve as reliable predictors of relapse in autoimmune pancreatitis?
    Song JM; Sun SY
    World J Gastroenterol; 2024 Feb; 30(5):512-515. PubMed ID: 38414589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative Rise of Serum IgG4 Levels After Steroid Therapy for Autoimmune Pancreatitis Predicts the Likelihood of Relapse.
    Suzuki D; Shimizu K; Tokushige K
    Pancreas; 2018 Apr; 47(4):412-417. PubMed ID: 29517627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term and long-term outcomes of autoimmune pancreatitis.
    Takuma K; Kamisawa T; Tabata T; Inaba Y; Egawa N; Igarashi Y
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):146-52. PubMed ID: 21287714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease.
    Okazaki K; Uchida K; Koyabu M; Miyoshi H; Takaoka M
    J Gastroenterol; 2011 Mar; 46(3):277-88. PubMed ID: 21452084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.